Omega Therapeutics Statistics
Total Valuation
OMGA has a market cap or net worth of $43.58 million. The enterprise value is $141.34 million.
Important Dates
The last earnings date was Thursday, November 14, 2024, after market close.
| Earnings Date | Nov 14, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
OMGA has 55.15 million shares outstanding. The number of shares has increased by 5.63% in one year.
| Current Share Class | 55.15M |
| Shares Outstanding | 55.15M |
| Shares Change (YoY) | +5.63% |
| Shares Change (QoQ) | +0.01% |
| Owned by Insiders (%) | 1.97% |
| Owned by Institutions (%) | 28.72% |
| Float | 21.33M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 5.38 |
| Forward PS | 18.02 |
| PB Ratio | 3.78 |
| P/TBV Ratio | 3.78 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 17.46 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.61, with a Debt / Equity ratio of 11.10.
| Current Ratio | 1.61 |
| Quick Ratio | 1.28 |
| Debt / Equity | 11.10 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -41.17 |
Financial Efficiency
Return on equity (ROE) is -166.90% and return on invested capital (ROIC) is -26.72%.
| Return on Equity (ROE) | -166.90% |
| Return on Assets (ROA) | -25.01% |
| Return on Capital (ROIC) | -26.72% |
| Revenue Per Employee | $86,117 |
| Profits Per Employee | -$777,574 |
| Employee Count | 94 |
| Asset Turnover | 0.04 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -63.07% in the last 52 weeks. The beta is 1.84, so OMGA's price volatility has been higher than the market average.
| Beta (5Y) | 1.84 |
| 52-Week Price Change | -63.07% |
| 50-Day Moving Average | 1.15 |
| 200-Day Moving Average | 2.14 |
| Relative Strength Index (RSI) | 32.59 |
| Average Volume (20 Days) | 348,951 |
Short Selling Information
The latest short interest is 6.36 million, so 11.54% of the outstanding shares have been sold short.
| Short Interest | 6.36M |
| Short Previous Month | 6.03M |
| Short % of Shares Out | 11.54% |
| Short % of Float | 29.83% |
| Short Ratio (days to cover) | 16.34 |
Income Statement
In the last 12 months, OMGA had revenue of $8.10 million and -$73.09 million in losses. Loss per share was -$1.33.
| Revenue | 8.10M |
| Gross Profit | -3.97M |
| Operating Income | -74.15M |
| Pretax Income | -78.90M |
| Net Income | -73.09M |
| EBITDA | -72.41M |
| EBIT | -74.15M |
| Loss Per Share | -$1.33 |
Full Income StatementBalance Sheet
The company has $30.38 million in cash and $128.13 million in debt, giving a net cash position of -$97.76 million or -$1.77 per share.
| Cash & Cash Equivalents | 30.38M |
| Total Debt | 128.13M |
| Net Cash | -97.76M |
| Net Cash Per Share | -$1.77 |
| Equity (Book Value) | 11.54M |
| Book Value Per Share | 0.21 |
| Working Capital | 14.78M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$55.58 million and capital expenditures -$2.06 million, giving a free cash flow of -$57.64 million.
| Operating Cash Flow | -55.58M |
| Capital Expenditures | -2.06M |
| Free Cash Flow | -57.64M |
| FCF Per Share | -$1.05 |
Full Cash Flow StatementMargins
| Gross Margin | -49.01% |
| Operating Margin | -916.01% |
| Pretax Margin | -902.93% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | -1,056.70% |